Cargando…
Hybrid mass spectrometry approaches in glycoprotein analysis and their usage in scoring biosimilarity
Many biopharmaceutical products exhibit extensive structural micro-heterogeneity due to an array of co-occurring post-translational modifications. These modifications often effect the functionality of the product and therefore need to be characterized in detail. Here, we present an integrative appro...
Autores principales: | Yang, Yang, Liu, Fan, Franc, Vojtech, Halim, Liem Andhyk, Schellekens, Huub, Heck, Albert J. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5105167/ https://www.ncbi.nlm.nih.gov/pubmed/27824045 http://dx.doi.org/10.1038/ncomms13397 |
Ejemplares similares
-
Quality Comparison of Biosimilar and Copy Filgrastim Products with the Innovator Product
por: Halim, Liem Andhyk, et al.
Publicado: (2018) -
Comprehensive Proteoform Characterization of Plasma Complement Component C8αβγ by Hybrid Mass Spectrometry Approaches
por: Franc, Vojtech, et al.
Publicado: (2018) -
Biosimilar therapeutics—what do we need to consider?
por: Schellekens, Huub
Publicado: (2009) -
Immunogenicity of Innovative and Biosimilar Monoclonal Antibodies
por: Doevendans, Erik, et al.
Publicado: (2019) -
Charting the
Proteoform Landscape of Serum Proteins
in Individual Donors by High-Resolution Native Mass Spectrometry
por: Cramer, Dario A. T., et al.
Publicado: (2022)